Cinven nabs Labco as a fourth pulled IPO morphs to PE buyout
Cinven announced on Thursday that it would buy Labco, the French medical diagnostics firm, the third time this year that a private equity firm has swept up a company that had failed to IPO, or where the flotation had found weak demand.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: